Who
Steven J. Romano
Director
Company insider
Files Form 4 as: Director, Dianthus Therapeutics; EVP and Chief R&D Officer, Silence Therapeutics; EVP & Chief Sci. Ofcr, Mallinckrodt.
In numbers
- Trades disclosed
- 44
- Buys
- 5
- Sells
- 0
- Bought
- $235K
- Sold
- $0
- Companies
- 3
- Companies where not an officer
- 1
- First trade
- 1 Jul 2015
- Last trade
- 21 May 2026
- Last filed
- 22 May 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 21 May 2026filed 22 May 2026 | DNTH Dianthus Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —6,090 at $0.00 | filing |
| 21 May 2026filed 22 May 2026 | DNTH Dianthus Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —6,090 at $0.00 | filing |
| 2 Jan 2026filed 6 Jan 2026 | SLN Silence Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —300,000 at $0.00 | filing |
| 2 Jan 2026filed 6 Jan 2026 | SLN Silence Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —300,000 at $0.00 | filing |
| 22 May 2025filed 22 May 2025 | DNTH Dianthus Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —12,500 at $0.00 | filing |
| 2 Jan 2025filed 6 Jan 2025 | SLN Silence Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —285,000 at $0.00 | filing |
| 16 Sep 2024filed 18 Sep 2024 | DNTH Dianthus Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —22,000 at $0.00 | filing |
| 16 Jun 2022filed 21 Jun 2022 | Mallinckrodtoption or derivative | SEC FORM 4 Code D | —11,275 at $0.00 | filing |
| 16 Jun 2022filed 21 Jun 2022 | Mallinckrodtoption or derivative | SEC FORM 4 Code D | —22,288 at $0.00 | filing |
| 16 Jun 2022filed 21 Jun 2022 | Mallinckrodtoption or derivative | SEC FORM 4 Code D | —59,731 at $0.00 | filing |
| 16 Jun 2022filed 21 Jun 2022 | Mallinckrodtoption or derivative | SEC FORM 4 Code D | —59,731 at $0.00 | filing |
| 16 Jun 2022filed 21 Jun 2022 | Mallinckrodtoption or derivative | SEC FORM 4 Code D | —189,201 at $0.00 | filing |
| 16 Jun 2022filed 21 Jun 2022 | Mallinckrodtoption or derivative | SEC FORM 4 Code D | —102,801 at $0.00 | filing |
| 16 Jun 2022filed 21 Jun 2022 | Mallinckrodt | SEC FORM 4 Code D | —72,637 at $0.00 | filing |
| 2 Apr 2020filed 3 Apr 2020 | Mallinckrodt | SEC FORM 4 Code F | $5,4403,022 at $1.80 | filing |
| 1 Apr 2020filed 3 Apr 2020 | Mallinckrodt | SEC FORM 4 Code F | $3,7131,924 at $1.93 | filing |
| 4 Jan 2020filed 7 Jan 2020 | Mallinckrodt | SEC FORM 4 Code F | $926284 at $3.26 | filing |
| 3 Jan 2020filed 7 Jan 2020 | Mallinckrodt | SEC FORM 4 Code F | $2,967883 at $3.36 | filing |
| 1 Jul 2019filed 3 Jul 2019 | Mallinckrodt | SEC FORM 4 Code F | $2,591285 at $9.09 | filing |
| 2 Apr 2019filed 3 Apr 2019 | Mallinckrodt | SEC FORM 4 Code F | $71K3,103 at $22.80 | filing |
News
No headline names them, or the companies they trade most, lately.